The newly launched Equetro Virtual Advisory Board (VAB) is a groundbreaking, interactive venue for thought leaders in Bipolar I Disorder. This scientific, members-only community offers private access to exclusive, featured content presented by the premier authorities on the effective treatment of Bipolar I. Membership is offered to a select group of forward thinking physicians, clinical experts, and research scientists committed to enhancing patient care through peer-to-peer collaboration and knowledge sharing.
VAB, which we developed and launched with Validus Pharmaceuticals, encourages and enables physician participation and communication through a variety of moderated comment and discussion tools within featured content pages. The first feature program is a four-part video series focusing on the unmet needs in Bipolar I. The presenters discuss the treatment of Bipolar I using the drug carbamazepine, and how carbamazepine evolved from discovery and clinical trials into the FDA-approved formulation, Equetro, that is used in clinical practice today.